Drug factory · FDA FEI 3012163998

Hugel, Inc.

23, Geodudanji 1-gil, Dongnae-myeon, Chuncheon-si, South Korea

South Korea: 1

Problems found, fixed voluntarily at FDA's last inspection, Oct 19, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

1 drug inspection on record since 2023: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
LetibotulinumtoxinaMakes it, makes the active ingredient, tests it, packages it and labels it Hugel, Inc. 81165-050, 81165-100

FDA inspection history

EndedResultProgramProblems noted
Oct 19, 2023Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture; label; manufacture; pack.